Vaso Corp 8-K Filing
Ticker: VASO · Form: 8-K · Filed: Nov 20, 2025 · CIK: 839087
| Field | Detail |
|---|---|
| Company | Vaso Corp (VASO) |
| Form Type | 8-K |
| Filed Date | Nov 20, 2025 |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Vaso Corp (ticker: VASO) to the SEC on Nov 20, 2025.
How long is this filing?
Vaso Corp's 8-K filing is 1 pages with approximately 401 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 401 words · 2 min read · ~1 pages · Grade level 11.2 · Accepted 2025-11-20 12:18:24
Filing Documents
- ea0266535-8k_vaso.htm (8-K) — 25KB
- ea026653501ex99-1_vaso.htm (EX-99.1) — 7KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- 0001213900-25-112966.txt ( ) — 195KB
- vaso-20251119.xsd (EX-101.SCH) — 3KB
- vaso-20251119_lab.xml (EX-101.LAB) — 33KB
- vaso-20251119_pre.xml (EX-101.PRE) — 22KB
- ea0266535-8k_vaso_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events On November 19, 2025, Vaso Corporation announced its agreement to sell its wholly-owned subsidiary, VasoHealthcare IT Corp. A press release announcing the transaction is attached as Exhibit 99.1.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits (d) Exhibits 99.1 November 19, 2025 Press Release 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: November 20, 2025 VASO CORPORATION By: /s/ Jun Ma Name: Jun Ma Title: Chief Executive Officer and President 2